FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to endocrinology and can be used for reduction of hypoglycemia acute exacerbation or severe hypoglycemia exacerbation in patients with type II diabetes after treatment with insulin. For this purpose vildagliptin or its salt is introduces to patient in combination with insulin.
EFFECT: invention ensures reduction of risk of hypoglycemia development, as well as necessity to apply several antihyperglycemic medications.
12 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC AGENT CONTAINING COMBINED USE OF COMBINATION OF DPP-IV INHIBITOR AND OTHER THERAPEUTIC AGENT FOR TREATING DIABETES | 2009 |
|
RU2523552C2 |
| NEW COMPOSITION | 2006 |
|
RU2821230C2 |
| NOVEL COMPOSITION | 2006 |
|
RU2483716C2 |
| ORGANIC COMPOUNDS | 2008 |
|
RU2489439C2 |
| PHARMACEUTICAL COMPOSITIONS | 2010 |
|
RU2532330C2 |
| SOLID DOSAGE FORM FOR ORAL ADMINISTRATION CONTAINING COMBINATION OF VILDAGLIPTIN AND GLIQUIDONE | 2014 |
|
RU2585378C1 |
| COMBINED THERAPY WITH GPR119 AGONISTS AND DPP-4 INHIBITORS | 2020 |
|
RU2818562C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING METABOLIC SYNDROME | 2011 |
|
RU2593960C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING METABOLIC SYNDROME | 2011 |
|
RU2732703C2 |
| DRY GRANULATION PROCESS FOR PRODUCING TABLET COMPOSITIONS OF METFORMIN AND COMPOSITIONS THEREOF | 2013 |
|
RU2647421C2 |
